Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bi-weekly Gemcitabine + nab-Paclitaxel in Pancreatic Cancer
NCT01851174Phase 2Terminated
- Sponsor
- Western Regional Medical Center
- Start
- Feb 2013
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, paclitaxel in pancreatic adenocarcinoma (PDAC), sponsored by Western Regional Medical Center. Started Feb 2013; status: terminated.
02
Drugs
gemcitabinepaclitaxel
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT01851174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01851174.